Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, January 22, 2022

FDA gives breakthrough designation to blood-based test for early prediction of Alzheimer’s

 

With your good chance of getting dementia this test should be prescribed by your doctor to establish a baseline for you. And then if found implement THOSE EXACT DEMENTIA PREVENTION PROTOCOLS  your doctor should have competently already set up.

Your risk of dementia, has your doctor told you of this?

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

The latest here:

FDA gives breakthrough designation to blood-based test for early prediction of Alzheimer’s

The FDA has granted breakthrough device designation to Diadem U.S. Inc. for AlzoSure Predict, its blood-based test for early prediction of Alzheimer’s disease.

The company’s blood-based biomarker prognostic assay is intended to determine with high accuracy whether people older than 50 years with signs of cognitive impairment may or may not progress to AD up to 6 years before the appearance of definitive symptoms.

Diadem supported its application to the FDA on positive data from a longitudinal study with 482 participants in this patient population. The study’s second phase includes biobank data from more than 1,000 additional participants from the U.S. and Europe and is set for completion in the coming months, according to a company release.

“Obtaining this FDA breakthrough device designation reinforces our view that AlzoSure Predict is a potential game changer for the early identification and management of [AD], which afflicts millions of patients and their families worldwide,” Paul Kinnon, CEO of Diadem, said in the release. “We see the breakthrough device designation as an important step in supporting the future commercialization of AlzoSure Predict in the U.S and globally, and we look forward to working closely with the FDA to complete our clinical studies and expedite the regulatory review process.”

 
Posted by at
Labels: , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)